{"id":"W1972272153","doi":"10.1016/j.lungcan.2014.04.014","title":"Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05)","year":2014,"lang":"en","type":"article","venue":"Lung Cancer","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Mach-Gaensslen Foundation of Canada","keywords":"Medicine; Erlotinib; Internal medicine; Oncology; Bevacizumab; Clinical endpoint; Lung cancer; Chemotherapy; Clinical trial; Cancer; Epidermal growth factor receptor","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001742025,0.0001513545,0.0004279128,0.0002057438,0.0002150521,0.0005284028,0.0001702282,0.0003708435,0.001020241],"category_scores_gemma":[0.0007385999,0.0001422649,0.0002565056,0.0003169097,0.0001161879,0.0002149111,0.0001312545,0.0004180079,0.0002640442],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002546692,"about_ca_system_score_gemma":0.000238102,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009727636,"about_ca_topic_score_gemma":0.001662414,"domain_scores_codex":[0.9998216,0.00002945236,0.00001793542,0.00005336868,0.0000360107,0.00004168229],"domain_scores_gemma":[0.9997304,0.00006488454,0.00008385976,0.00001406654,0.00003431556,0.00007242909],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01395741,0.0003478397,0.9281372,0.00007056948,0.0002482353,0.001104908,0.0002241144,0.0002519797,0.03152805,0.00009326266,0.0009845711,0.02305182],"study_design_scores_gemma":[0.0001387615,0.001900861,0.9924265,0.000009195153,0.0001652946,0.001205989,0.0001632016,0.0006480075,0.00226191,0.00006496436,0.001002797,0.00001259847],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9989097,0.0002668315,0.00006264957,0.00003964874,0.00001408943,0.000007746307,0.0003012424,0.000005797418,0.0003923912],"genre_scores_gemma":[0.9987949,0.000081119,0.0001178465,0.00007161123,0.00001296966,0.00001445237,0.0004723318,0.000003562221,0.0004311093],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001020241,"threshold_uncertainty_score":0.003413081,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.003084220057585393,"score_gpt":0.2517207422601649,"score_spread":0.2486365222025796,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}